株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

バイオ医薬品の世界市場

Biopharmaceuticals

発行 Global Industry Analysts, Inc. 商品コード 335296
出版日 ページ情報 英文 277 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
バイオ医薬品の世界市場 Biopharmaceuticals
出版日: 2019年10月01日 ページ情報: 英文 277 Pages
概要

当レポートでは、世界のバイオ医薬品市場について調査し、業界・製品の概要や、世界市場の全体的見通し (直近・今後の7年間の推定値・予測値)、最近の市場動向、部門別および各地域・主要国市場の詳細動向などを分析すると共に、主な企業プロファイル (全514社分) をも盛り込んでお届けいたします。

第1章 イントロダクション・調査方法・製品定義

第2章 エグゼクティブ・サマリー

  • 産業概要
    • 生物製剤:従来型の医薬品市場に取って代わる存在
    • 現状・将来性の分析
    • 市場競争
    • 特許満了の状況 (2015年)
    • 市場促進要因
    • 市場抑制要因
    • バイオ医薬品の製品上市の動き (2014~2015年)
    • 研究開発 (R&D) 資金調達の重要性
  • 部門別分析
    • モノクローナル抗体:最も発展している分野
    • インスリン:高い潜在性のある分野
    • 遺伝子組み換え型治療用タンパク質
    • ワクチン市場のダイナミクス
  • 開発パイプライン上のバイオ医薬品
    • 開発中のインスリン製品
  • 市場の傾向
    • 製造現場で好まれている使い捨て型システム
    • バイオシミラーの重要性の拡大
    • サプライチェーン管理:治験における重要性
    • 植物由来製品の哺乳類細胞培養システムに対する優位性
    • 赤血球生成促進剤 (ESA) に関する安全上・効率上の課題
    • hMSCベース療法に伴う、増殖因子のニーズ拡大
    • 肝細胞療法の人気拡大
    • コスト効率的な手法の開発:目下の課題
    • 企業合併・買収 (M&A) 活動は引き続き活発
    • 長期的な成功を決定する要因
    • イノベーション
  • バイオ医薬品:概要
    • バイオ医薬品の製造・保存に関する規制環境
    • 用語集
    • バイオ医薬品の進化
    • バイオ医薬品の製造方法
    • バイオ医薬品の生産に関する主な懸念事項
    • 将来のバイオ医薬品の製造方法
    • バイオ医薬品の技術的特徴
    • バイオ医薬品の種類
      • インスリン
      • モノクローナル抗体
      • 遺伝子組み換え型タンパク質
      • ワクチン
  • 製品開発・発売 (全14件)
  • 最近の業界活動 (全29件)
  • 主要企業の分析
    • AbbVie, Inc. (米国)
    • Anavex Life Sciences Corp. (米国)
    • Baxter International, Inc. (米国)
    • Bayer HealthCare Pharmaceuticals, Inc. (米国)
    • Biocon (インド)
    • Eli Lilly (米国)
    • F. Hoffmann-La Roche Ltd. (Switzerland)
      • Genentech (米国)
    • GlaxoSmithKline (英国)
    • Janssen Biotech, Inc. (米国)
    • Kemwell Biopharma (インド)
    • Novartis (スイス)
      • Sandoz
    • Pfizer, Inc. (米国)
    • Sun Pharmaceutical Industries Ltd. (インド)
    • Sanofi S.A. (フランス)
  • 世界市場の見通し
    • 製品セグメント別の詳細

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • 他の欧州諸国
  • アジア太平洋地域
  • 他の国々 (RoW)

第4章 競争環境

目次
Product Code: MCP-7003

Biopharmaceuticals market worldwide is projected to grow by US$296.9 Billion, driven by a compounded growth of 13.6%. Monoclonal Antibody, one of the segments analyzed and sized in this study, displays the potential to grow at over 13.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$173.7 Billion by the year 2025, Monoclonal Antibody will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 12.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$11.7 Billion to the region's size and clout in the next 5 to 6 years. Over US$9.7 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Monoclonal Antibody will reach a market size of US$8.9 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 17.4% over the next couple of years and add approximately US$71.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Abbott Diagnostics, Inc. - Core Laboratory; Amgen, Inc.; Biogen, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche AG; Johnson & Johnson; Merck & Co., Inc.; Novo Nordisk A/S; Pfizer, Inc.; Sanofi

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Biopharmaceuticals Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Biopharmaceuticals Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Biopharmaceuticals Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Biopharmaceuticals Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Monoclonal Antibody (Product) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Monoclonal Antibody (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Monoclonal Antibody (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Interferon (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Interferon (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Interferon (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Insulin (Product) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Insulin (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Insulin (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Growth & Coagulation Factor (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Growth & Coagulation Factor (Product) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Growth & Coagulation Factor (Product) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Erythropoietin (Product) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Erythropoietin (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Erythropoietin (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Vaccine (Product) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Vaccine (Product) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Vaccine (Product) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Hormone (Product) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
  • TABLE 23: Hormone (Product) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
  • TABLE 24: Hormone (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Other Products (Product) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 26: Other Products (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 27: Other Products (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 28: Oncology (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 29: Oncology (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 30: Oncology (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 31: Blood Disorder (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
  • TABLE 32: Blood Disorder (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 33: Blood Disorder (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 34: Metabolic Disease (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 35: Metabolic Disease (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 36: Metabolic Disease (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 37: Infectious Disease (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
  • TABLE 38: Infectious Disease (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017
  • TABLE 39: Infectious Disease (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
  • TABLE 40: Cardiovascular Disease (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
  • TABLE 41: Cardiovascular Disease (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 42: Cardiovascular Disease (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 43: Neurological Disease (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025
  • TABLE 44: Neurological Disease (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
  • TABLE 45: Neurological Disease (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
  • TABLE 46: Immunology (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 47: Immunology (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 48: Immunology (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 49: Other Applications (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
  • TABLE 50: Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 51: Other Applications (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Biopharmaceuticals Market Share (in %) by Company: 2019 & 2025
    • TABLE 52: United States Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 53: Biopharmaceuticals Market in the United States by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 54: United States Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 55: United States Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 56: Biopharmaceuticals Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017
    • TABLE 57: Biopharmaceuticals Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 58: Canadian Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 59: Canadian Biopharmaceuticals Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 60: Biopharmaceuticals Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 61: Canadian Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 62: Biopharmaceuticals Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 63: Canadian Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • JAPAN
    • TABLE 64: Japanese Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 65: Biopharmaceuticals Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 66: Japanese Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 67: Japanese Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025
    • TABLE 68: Japanese Biopharmaceuticals Market in US$ Million by Application: 2009-2017
    • TABLE 69: Biopharmaceuticals Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 70: Chinese Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 71: Biopharmaceuticals Historic Market Analysis in China in US$ Million by Product: 2009-2017
    • TABLE 72: Chinese Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 73: Chinese Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025
    • TABLE 74: Biopharmaceuticals Market Review in China in US$ Million by Application: 2009-2017
    • TABLE 75: Chinese Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 76: Biopharmaceuticals Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 77: French Biopharmaceuticals Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 78: French Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 79: Biopharmaceuticals Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025
    • TABLE 80: French Biopharmaceuticals Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 81: French Biopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Biopharmaceuticals Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 82: European Biopharmaceuticals Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 83: Biopharmaceuticals Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 84: European Biopharmaceuticals Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 85: European Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 86: Biopharmaceuticals Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 87: European Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 88: European Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 89: Biopharmaceuticals Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 90: European Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 91: Biopharmaceuticals Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 92: German Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 93: German Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 94: Biopharmaceuticals Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 95: German Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 96: Biopharmaceuticals Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 97: Italian Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 98: Biopharmaceuticals Historic Market Analysis in Italy in US$ Million by Product: 2009-2017
    • TABLE 99: Italian Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 100: Italian Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025
    • TABLE 101: Biopharmaceuticals Market Review in Italy in US$ Million by Application: 2009-2017
    • TABLE 102: Italian Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 103: United Kingdom Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 104: Biopharmaceuticals Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 105: United Kingdom Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 106: United Kingdom Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025
    • TABLE 107: United Kingdom Biopharmaceuticals Market in US$ Million by Application: 2009-2017
    • TABLE 108: Biopharmaceuticals Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 109: Spanish Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 110: Spanish Biopharmaceuticals Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 111: Biopharmaceuticals Market in Spain: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 112: Spanish Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 113: Biopharmaceuticals Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 114: Spanish Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • RUSSIA
    • TABLE 115: Russian Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 116: Biopharmaceuticals Market in Russia by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 117: Russian Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 118: Russian Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 119: Biopharmaceuticals Historic Demand Patterns in Russia by Application in US$ Million for 2009-2017
    • TABLE 120: Biopharmaceuticals Market Share Breakdown in Russia by Application: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 121: Rest of Europe Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 122: Biopharmaceuticals Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 123: Rest of Europe Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 124: Rest of Europe Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 125: Biopharmaceuticals Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 126: Rest of Europe Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 127: Asia-Pacific Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 128: Biopharmaceuticals Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 129: Asia-Pacific Biopharmaceuticals Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 130: Biopharmaceuticals Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 131: Asia-Pacific Biopharmaceuticals Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 132: Asia-Pacific Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 133: Biopharmaceuticals Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025
    • TABLE 134: Asia-Pacific Biopharmaceuticals Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 135: Asia-Pacific Biopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • AUSTRALIA
    • TABLE 136: Biopharmaceuticals Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 137: Australian Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 138: Australian Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 139: Biopharmaceuticals Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 140: Australian Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 141: Biopharmaceuticals Market Share Distribution in Australia by Application: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 142: Indian Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 143: Indian Biopharmaceuticals Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 144: Biopharmaceuticals Market in India: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 145: Indian Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 146: Biopharmaceuticals Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 147: Indian Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • SOUTH KOREA
    • TABLE 148: Biopharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 149: South Korean Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 150: Biopharmaceuticals Market Share Distribution in South Korea by Product: 2009 VS 2019 VS 2025
    • TABLE 151: Biopharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025
    • TABLE 152: South Korean Biopharmaceuticals Historic Market Analysis in US$ Million by Application: 2009-2017
    • TABLE 153: Biopharmaceuticals Market Share Distribution in South Korea by Application: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 154: Rest of Asia-Pacific Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 155: Biopharmaceuticals Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 156: Rest of Asia-Pacific Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 157: Rest of Asia-Pacific Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025
    • TABLE 158: Rest of Asia-Pacific Biopharmaceuticals Market in US$ Million by Application: 2009-2017
    • TABLE 159: Biopharmaceuticals Market Share Shift in Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 160: Latin American Biopharmaceuticals Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 161: Biopharmaceuticals Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 162: Latin American Biopharmaceuticals Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 163: Latin American Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 164: Biopharmaceuticals Historic Market Analysis in Latin America in US$ Million by Product: 2009-2017
    • TABLE 165: Latin American Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 166: Latin American Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025
    • TABLE 167: Biopharmaceuticals Market Review in Latin America in US$ Million by Application: 2009-2017
    • TABLE 168: Latin American Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • ARGENTINA
    • TABLE 169: Argentinean Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 170: Biopharmaceuticals Market in Argentina in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 171: Argentinean Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 172: Argentinean Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 173: Biopharmaceuticals Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 174: Argentinean Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 175: Biopharmaceuticals Market in Brazil by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 176: Brazilian Biopharmaceuticals Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 177: Brazilian Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 178: Biopharmaceuticals Quantitative Demand Analysis in Brazil in US$ Million by Application: 2018-2025
    • TABLE 179: Brazilian Biopharmaceuticals Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 180: Brazilian Biopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • MEXICO
    • TABLE 181: Biopharmaceuticals Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 182: Mexican Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 183: Mexican Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 184: Biopharmaceuticals Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 185: Mexican Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 186: Biopharmaceuticals Market Share Distribution in Mexico by Application: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 187: Rest of Latin America Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 188: Biopharmaceuticals Market in Rest of Latin America by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 189: Rest of Latin America Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 190: Rest of Latin America Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 191: Biopharmaceuticals Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2009-2017
    • TABLE 192: Biopharmaceuticals Market Share Breakdown in Rest of Latin America by Application: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 193: The Middle East Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 194: Biopharmaceuticals Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 195: The Middle East Biopharmaceuticals Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 196: The Middle East Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 197: The Middle East Biopharmaceuticals Historic Market by Product in US$ Million: 2009-2017
    • TABLE 198: Biopharmaceuticals Market in the Middle East: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 199: The Middle East Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 200: Biopharmaceuticals Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 201: The Middle East Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • IRAN
    • TABLE 202: Iranian Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 203: Biopharmaceuticals Market in Iran: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 204: Iranian Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 205: Iranian Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025
    • TABLE 206: Iranian Biopharmaceuticals Market in US$ Million by Application: 2009-2017
    • TABLE 207: Biopharmaceuticals Market Share Shift in Iran by Application: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 208: Israeli Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 209: Biopharmaceuticals Market in Israel in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 210: Israeli Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 211: Israeli Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 212: Biopharmaceuticals Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 213: Israeli Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 214: Saudi Arabian Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 215: Biopharmaceuticals Historic Market Analysis in Saudi Arabia in US$ Million by Product: 2009-2017
    • TABLE 216: Saudi Arabian Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 217: Saudi Arabian Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025
    • TABLE 218: Biopharmaceuticals Market Review in Saudi Arabia in US$ Million by Application: 2009-2017
    • TABLE 219: Saudi Arabian Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • UNITED ARAB EMIRATES
    • TABLE 220: Biopharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 221: United Arab Emirates Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 222: Biopharmaceuticals Market Share Distribution in United Arab Emirates by Product: 2009 VS 2019 VS 2025
    • TABLE 223: Biopharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025
    • TABLE 224: United Arab Emirates Biopharmaceuticals Historic Market Analysis in US$ Million by Application: 2009-2017
    • TABLE 225: Biopharmaceuticals Market Share Distribution in United Arab Emirates by Application: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 226: Biopharmaceuticals Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 227: Rest of Middle East Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 228: Rest of Middle East Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 229: Biopharmaceuticals Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 230: Rest of Middle East Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 231: Biopharmaceuticals Market Share Distribution in Rest of Middle East by Application: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 232: African Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 233: Biopharmaceuticals Market in Africa by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 234: African Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 235: African Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 236: Biopharmaceuticals Historic Demand Patterns in Africa by Application in US$ Million for 2009-2017
    • TABLE 237: Biopharmaceuticals Market Share Breakdown in Africa by Application: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBOTT DIAGNOSTICS, INC. - CORE LABORATORY
  • AMGEN
  • BIOGEN
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVO NORDISK A/S
  • PFIZER, INC
  • SANOFI

V. CURATED RESEARCH

Back to Top